216 related articles for article (PubMed ID: 22819499)
61. Stability of prostaglandin E(2) (PGE (2)) embedded in poly-D,L: -lactide-co-glycolide microspheres: a pre-conditioning approach for tissue engineering applications.
Watzer B; Zehbe R; Halstenberg S; James Kirkpatrick C; Brochhausen C
J Mater Sci Mater Med; 2009 Jun; 20(6):1357-65. PubMed ID: 19160024
[TBL] [Abstract][Full Text] [Related]
62. Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA.
Dailey LA; Kleemann E; Wittmar M; Gessler T; Schmehl T; Roberts C; Seeger W; Kissel T
Pharm Res; 2003 Dec; 20(12):2011-20. PubMed ID: 14725368
[TBL] [Abstract][Full Text] [Related]
63. Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(D,L-lactide-co-glycolide): effects of polymer structure on in vitro degradation behaviour.
Unger F; Wittmar M; Morell F; Kissel T
Biomaterials; 2008 May; 29(13):2007-14. PubMed ID: 18262641
[TBL] [Abstract][Full Text] [Related]
64. The effect of different grades of PLGA on characteristics of microspheres encapsulated with cyclosporine A.
Malaekeh-Nikouei B; Sajadi Tabassi SA; Jaafari MR
Curr Drug Deliv; 2006 Oct; 3(4):343-9. PubMed ID: 17076635
[TBL] [Abstract][Full Text] [Related]
65. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
66. Protein release microparticles based on the blend of poly(D,L-lactic-co-glycolic acid) and oligo-ethylene glycol grafted poly(L-lactide).
Cho KY; Choi SH; Kim CH; Nam YS; Park TG; Park JK
J Control Release; 2001 Oct; 76(3):275-84. PubMed ID: 11578742
[TBL] [Abstract][Full Text] [Related]
67. Double walled POE/PLGA microspheres: encapsulation of water-soluble and water-insoluble proteins and their release properties.
Shi M; Yang YY; Chaw CS; Goh SH; Moochhala SM; Ng S; Heller J
J Control Release; 2003 Apr; 89(2):167-77. PubMed ID: 12711441
[TBL] [Abstract][Full Text] [Related]
68. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
Jain RA
Biomaterials; 2000 Dec; 21(23):2475-90. PubMed ID: 11055295
[TBL] [Abstract][Full Text] [Related]
69. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
Woo BH; Jiang G; Jo YW; DeLuca PP
Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
[TBL] [Abstract][Full Text] [Related]
70. Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics.
Gabor F; Ertl B; Wirth M; Mallinger R
J Microencapsul; 1999; 16(1):1-12. PubMed ID: 9972498
[TBL] [Abstract][Full Text] [Related]
71. Controlling degradation of acid-hydrolyzable pluronic hydrogels by physical entrapment of poly(lactic acid-co-glycolic acid) microspheres.
Lee JB; Chun KW; Yoon JJ; Park TG
Macromol Biosci; 2004 Oct; 4(10):957-62. PubMed ID: 15487026
[TBL] [Abstract][Full Text] [Related]
72. In vitro performance of carbamazepine loaded to various molecular weights of poly (D,L-lactide-co-glycolide).
Barakat NS; Radwan MA
Drug Deliv; 2006; 13(1):9-18. PubMed ID: 16401588
[TBL] [Abstract][Full Text] [Related]
73. Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles.
Shenderova A; Burke TG; Schwendeman SP
Pharm Res; 1997 Oct; 14(10):1406-14. PubMed ID: 9358554
[TBL] [Abstract][Full Text] [Related]
74. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
75. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems.
Schrier JA; DeLuca PP
Pharm Dev Technol; 1999; 4(4):611-21. PubMed ID: 10578516
[TBL] [Abstract][Full Text] [Related]
76. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.
Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP
J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441
[TBL] [Abstract][Full Text] [Related]
77. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip.
Grayson AC; Voskerician G; Lynn A; Anderson JM; Cima MJ; Langer R
J Biomater Sci Polym Ed; 2004; 15(10):1281-304. PubMed ID: 15559850
[TBL] [Abstract][Full Text] [Related]
78. Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis.
Cevher E; Orhan Z; Sensoy D; Ahiskali R; Kan PL; Sağirli O; Mülazimoğlu L
J Microencapsul; 2007 Sep; 24(6):577-95. PubMed ID: 17654177
[TBL] [Abstract][Full Text] [Related]
79. Comparison of the effects of Mg(OH)2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(D,L-lactide-co-glycolide) implants.
Kang J; Schwendeman SP
Biomaterials; 2002 Jan; 23(1):239-45. PubMed ID: 11762843
[TBL] [Abstract][Full Text] [Related]
80. Drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-co-glycolide) and poly(dl-lactide).
Matsumoto A; Matsukawa Y; Suzuki T; Yoshino H
J Control Release; 2005 Aug; 106(1-2):172-80. PubMed ID: 15936109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]